Vaginal mesh implants, devices used to treat pelvic organ prolapse and stress urinary incontinence, have repeatedly hit the headlines over the last few years, as women who suffered serious complications caused by the devices eroding through the tissue battle mesh makers in court. Payouts to these patients in the US have so far totalled several billion dollars and, more recently, over 800 women in the UK are taking legal action against the National Health Service. One member of UK Parliament has also advocated a further government investigation into the use of the surgical mesh.
“When pelvic mesh was first launched in the 1990s, it was not anticipated that it would have so many adverse events post-market,” says Steve Atkinson, CEO of Irish firm Atlantic...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?